A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
Top Cited Papers
Open Access
- 1 December 2014
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 22 (12) , 2118-2129
- https://doi.org/10.1038/mt.2014.133
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- RNA: The new revolution in nucleic acid vaccinesSeminars in Immunology, 2013
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA VaccinesMolecular Therapy, 2013
- The mechanism of action of MF59 – An innately attractive adjuvant formulationPublished by Elsevier ,2012
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune ResponsesPLOS ONE, 2012
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodesVaccine, 2011
- Expression of therapeutic proteins after delivery of chemically modified mRNA in miceNature Biotechnology, 2011
- DNA vaccines: an historical perspective and view to the futureImmunological Reviews, 2010
- Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein in MF59 AdjuvantJournal of Virology, 2010
- Therapeutic and prophylactic applications of alphavirus vectorsExpert Reviews in Molecular Medicine, 2008
- Low toxicity of cationic lipid-based emulsion for gene transferBiomaterials, 2004